Ovarian transposition and cervical cancer

Area of Science:

• Gynecologic Oncology
• Reproductive Medicine
• Oncology

Background:

• Cervical cancer is a leading malignancy affecting women globally.
• Balancing oncological treatment with reproductive benefit is increasingly important for patients.
• Fertility preservation options are crucial for pre-menopausal women diagnosed with cervical cancer.

Purpose of the Study:

• To review the literature on ovarian transposition in cervical cancer patients.
• To provide guidance for gynecologic oncology surgeons on counseling patients regarding fertility preservation.
• To address the controversy and underutilization of ovarian transposition.

Main Methods:

• Literature review synthesizing available data on ovarian transposition.
• Analysis of functional outcomes, safety, and oncological risks.
• Discussion of clinical trial scarcity and data limitations.

Main Results:

• Ovarian transposition is a safe fertility preservation option in cervical cancer.
• High rates of ovarian function preservation are observed.
• Acceptable rates of ovarian cysts and negligible risk of metastases in transposed ovaries.

Conclusions:

• Ovarian transposition is a viable fertility preservation strategy for pre-menopausal women with cervical cancer.
• Despite some controversy, it offers significant benefits in preserving ovarian function.
• Further clinical trials are needed to solidify its role and address data gaps.